Articles:
Publications:

3 hours ago

<![CDATA[Ebola Antiviral Being Used in Current Outbreak Advances Through Dual Development Strategy]]>

Island Pharmaceuticals is collecting its first prospective human clinical data on investigational antiviral galidesivir during the ongoing Bundibugyo Ebola outbreak. Deployed under the World Health Organization's Monitored Emergency Use of... Read more.

More on this topic

ContagionLive 3 hours ago
Turn on Transparency.
Owner: Mike Hennessy Jr. through MJH Healthcare Holdings, LLC More info
ContagionLive 3 hours ago
Turn on Transparency.
Owner: Mike Hennessy Jr. through MJH Healthcare Holdings, LLC More info
Times News Global 4 hours ago
Turn on Transparency.
Elon Musk’s USAID cuts blamed for worsening Ebola outbreak in DRC
Owner: Non-transparent More info
More

More from ContagionLive

ContagionLive 3 hours ago
Turn on Transparency.
Owner: Mike Hennessy Jr. through MJH Healthcare Holdings, LLC More info
ContagionLive 3 hours ago
Turn on Transparency.
Owner: Mike Hennessy Jr. through MJH Healthcare Holdings, LLC More info
ContagionLive Jul. 13, 2026
Turn on Transparency.
Owner: Mike Hennessy Jr. through MJH Healthcare Holdings, LLC More info
More

Keep exploring Perspectify!

Create a free account and bring
more transparency to your news.

Already have an account? Log in.

Today's Media Watch

Your daily guide to the stories shaping media, journalism, and public trust.

12 hours ago
Japan Enacts Bills to Fight Election Misinformation
Neutral | Owner: Nippon Communications Foundation
12 hours ago
Nigeria: Kano Court Upholds Journalists’ Right to Protect Sources
Neutral | Owner: Daily Post Media Ltd
12 hours ago
LA Federal Judge Orders DHS to Stop Using Force Against Journalists
Neutral | Owner: Bradley Family

Learn About Our Fact-Based Transparency System

Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.

Learn more